CD8A and neoplasm: Previous studies showed that both tumor-derived and dendritic cell-derived exosomes stimulate tumor antigen-specific CD8+ cytotoxic T lymphocyte responses; moreover, these exosomes can induce antitumor immunity in experimental animal models and human clinical trials for colorectal, metastatic skin, and non-small cell lung cancers [173,174].